201. Apolipoprotein E-ε4 allele predicts escalation of psychotic symptoms in late adulthood.
- Author
-
Jonas K, Clouston S, Li K, Fochtmann LJ, Lencz T, Malhotra AK, Cicero D, Perlman G, Bromet EJ, and Kotov R
- Subjects
- Adult, Age Factors, Aged, Delusions psychology, Disease Progression, Female, Hallucinations psychology, Humans, Longitudinal Studies, Male, Middle Aged, Prognosis, Psychotic Disorders psychology, Apolipoprotein E4 genetics, Delusions genetics, Hallucinations genetics, Psychotic Disorders genetics, Schizophrenia genetics, Schizophrenic Psychology
- Abstract
Background: Research on a putative link between apolipoprotein-ε4 allele (APOE-ε4) and schizophrenia has been inconclusive. However, prior studies have not investigated the association between APOE-ε4 and symptom trajectories, nor has the existing literature taken into account the potentially moderating effect of age in genetic association studies., Methods: The association between APOE-ε4 and four symptom dimensions was investigated in a longitudinal study of 116 individuals with schizophrenia initially assessed during their first admission for psychosis and evaluated five times over the following 20years. A meta-analysis identified 29 case-control studies of APOE-ε4 allele frequency in schizophrenia, which were analyzed using random-effects meta-regression to test the potentially moderating effect of age., Results: Longitudinal models identified a specific association between APOE-ε4 and symptom trajectories, showing that APOE-ε4 portends worsening severity of hallucinations and delusions in late adulthood among people with schizophrenia, at a rate of a 0.46 standard deviation increase per decade. Meta-analysis showed a significant effect of age: the association between APOE-ε4 and schizophrenia was not detectable in younger people but became pronounced with age, such that APOE-ε4 increased the odds of diagnosis by 10% per decade., Conclusions: Taken together, the meta-analysis and longitudinal analysis implicate APOE-ε4 as an age-related risk factor for worsening hallucinations and delusions, and suggest APOE-ε4 may play an age-mediated pathophysiological role in schizophrenia. The presence of an APOE-ε4 allele may also identify a subgroup of patients who require intensive monitoring and additional targeted interventions, especially in mid-to late-life., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF